Nothing Special   »   [go: up one dir, main page]

ES2138625T3 - Uso de enzimas especialmente bromelaina, en el tratamiento de diarrea no infecciosa. - Google Patents

Uso de enzimas especialmente bromelaina, en el tratamiento de diarrea no infecciosa.

Info

Publication number
ES2138625T3
ES2138625T3 ES93914851T ES93914851T ES2138625T3 ES 2138625 T3 ES2138625 T3 ES 2138625T3 ES 93914851 T ES93914851 T ES 93914851T ES 93914851 T ES93914851 T ES 93914851T ES 2138625 T3 ES2138625 T3 ES 2138625T3
Authority
ES
Spain
Prior art keywords
pct
treatment
bromelain
infectious diarrhea
enzymes especially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93914851T
Other languages
English (en)
Inventor
Tracey Leahanne Mynott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929213862A external-priority patent/GB9213862D0/en
Priority claimed from GB939308164A external-priority patent/GB9308164D0/en
Priority claimed from GB939313189A external-priority patent/GB9313189D0/en
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Application granted granted Critical
Publication of ES2138625T3 publication Critical patent/ES2138625T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE HA OBSERVADO QUE ENZIMAS, ESPECIALMENTE LAS ENZIMAS PROTEOLITICAS COMO LA BROMELINA, INHIBEN LA ACCION DE LA TOXINA (LT) DE CALOR LABIL DE LA ESCHERICHIA COLI ENTEROTOXIGENICA. SON POR CONSIGUIENTE BENEFICIOSAS EN LA PROFILAXIS, GESTION Y TRATAMIENTO DE LA DIARREA EN LOS HUMANOS.
ES93914851T 1992-06-30 1993-06-30 Uso de enzimas especialmente bromelaina, en el tratamiento de diarrea no infecciosa. Expired - Lifetime ES2138625T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929213862A GB9213862D0 (en) 1992-06-30 1992-06-30 Medical use of enzymes
GB939308164A GB9308164D0 (en) 1993-04-20 1993-04-20 Medical use of enzymes
GB939313189A GB9313189D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes

Publications (1)

Publication Number Publication Date
ES2138625T3 true ES2138625T3 (es) 2000-01-16

Family

ID=27266268

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93914851T Expired - Lifetime ES2138625T3 (es) 1992-06-30 1993-06-30 Uso de enzimas especialmente bromelaina, en el tratamiento de diarrea no infecciosa.

Country Status (14)

Country Link
US (1) US5928640A (es)
EP (1) EP0671943B1 (es)
JP (1) JPH08503691A (es)
AT (1) ATE184200T1 (es)
AU (1) AU672986B2 (es)
CA (1) CA2137674A1 (es)
DE (1) DE69326351T2 (es)
DK (1) DK0671943T3 (es)
ES (1) ES2138625T3 (es)
GR (1) GR3031961T3 (es)
HK (1) HK1004193A1 (es)
NZ (1) NZ253748A (es)
SG (1) SG42846A1 (es)
WO (1) WO1994000147A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
WO1998038291A1 (en) * 1997-02-25 1998-09-03 Cortecs (Uk) Limited Component of bromelain
CN1252101A (zh) * 1997-02-25 2000-05-03 科特克斯(英国)有限公司 菠萝蛋白酶成分
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
CA2333252C (en) * 1998-07-15 2008-11-25 Ursapharm Arzneimittel Gmbh Use of bromelain proteases for inhibiting blood coagulation
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
US20040166198A1 (en) * 2001-04-25 2004-08-26 Kiers Jeroen Lucas Process for the manufacture of a fermented health-promoting product
MX2007004534A (es) * 2004-10-14 2007-11-08 Altus Pharmaceuticals Inc Composiciones que contienen lipasa, proteasa y amilasa para tratar la insuficiencia pancreatica.
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US9148409B2 (en) 2005-06-30 2015-09-29 The Chamberlain Group, Inc. Method and apparatus to facilitate message transmission and reception using different transmission characteristics
US12149618B2 (en) 2005-01-27 2024-11-19 The Chamberlain Group Llc Method and apparatus to facilitate transmission of an encrypted rolling code
US8422667B2 (en) 2005-01-27 2013-04-16 The Chamberlain Group, Inc. Method and apparatus to facilitate transmission of an encrypted rolling code
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
EP3408387B1 (en) 2016-01-31 2022-01-05 Mediwound Ltd Debriding composition for treating wounds
US10652743B2 (en) 2017-12-21 2020-05-12 The Chamberlain Group, Inc. Security system for a moveable barrier operator
US11074773B1 (en) 2018-06-27 2021-07-27 The Chamberlain Group, Inc. Network-based control of movable barrier operators for autonomous vehicles
WO2020028502A1 (en) 2018-08-01 2020-02-06 The Chamberlain Group, Inc. Movable barrier operator and transmitter pairing over a network
US10997810B2 (en) 2019-05-16 2021-05-04 The Chamberlain Group, Inc. In-vehicle transmitter training

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617417A1 (de) * 1966-12-08 1971-03-25 Ciba Geigy Pharmazeutisches Praeparat
JPS5299207A (en) * 1976-02-16 1977-08-19 Kaken Pharmaceut Co Ltd Remedy for cattle diarrhea
FR2414554A1 (fr) * 1978-01-13 1979-08-10 Steeg Lottie Nouveau milieu de culture bacterienne et ses applications comme additif alimentaire et medicament pour animaux
AU604052B2 (en) * 1986-08-28 1990-12-06 Enzacor Properties Limited Animal growth promotant
AU609419B2 (en) * 1986-08-28 1991-05-02 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
EP0596962A4 (en) * 1991-07-24 1997-01-15 Enzacor Pty Ltd Therapeutic compositions and methods.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
AU4507493A (en) 1994-01-24
GR3031961T3 (en) 2000-03-31
DK0671943T3 (da) 2000-03-27
WO1994000147A1 (en) 1994-01-06
DE69326351D1 (de) 1999-10-14
EP0671943A1 (en) 1995-09-20
US5928640A (en) 1999-07-27
DE69326351T2 (de) 2000-05-18
AU672986B2 (en) 1996-10-24
HK1004193A1 (en) 1998-11-20
JPH08503691A (ja) 1996-04-23
NZ253748A (en) 1997-06-24
CA2137674A1 (en) 1994-01-06
EP0671943B1 (en) 1999-09-08
SG42846A1 (en) 1997-10-17
ATE184200T1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
ES2138625T3 (es) Uso de enzimas especialmente bromelaina, en el tratamiento de diarrea no infecciosa.
ES2078738T3 (es) Composicion y procedimiento para eliminar o prevenir la aparicion de biopeliculas.
DE3867853D1 (de) Mikroorganismusstamm mit antimicrobieller wirkung.
DK0675708T3 (da) Farmaceutiske og dermokosmetiske sammensætninger indeholdende heste-colostrum.
NO305386B1 (no) FremgangsmÕte for underkritisk t°rking av aerogeler
ES2111578T3 (es) Formulacion antimicrobiana con ph controlado.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
ATE169445T1 (de) Verwendung von gelformulierungen als beizmittel
AU5699494A (en) Novel liquid phenolic antioxidants
DE69434071D1 (de) Antimikrobielle proteine
FI961054A0 (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
BR9007636A (pt) Bio-herbicida combinando agentes quimicos e patogenos de plantas bacterianos
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
SI0874718T1 (en) Use of an agent based on natural active substances for protecting technical materials against damages and destruction by harmful organisms
DK1033993T3 (da) Anvendelse af Escherichia coli stamme DSM 6601 i veterinærsektoren til behandling af diarré
AU5625194A (en) Rectal flunisolide compositions for treating inflammatory intestinal disorders
ZA939227B (en) Novel triazoloquinazolines,their preparation and use
DK0601005T3 (da) Detergentenzymer
GEP19991603B (en) Iersinia Enterocolitica Bacteriophage Strain Consortium

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 671943

Country of ref document: ES